Tian Yu Y - OmicsDI

Show results for

Unknown (2392)
Proteomics (76)
Transcriptomics (11)
Genomics (7)
Metabolomics (4)

Organisms

Homo sapiens (45)
Andropogon gerardi (27)
Bacteria (27)
Canis lupus familiaris (27)
Cnidaria (27)
Cricetulus griseus (27)
Eukaryota (27)
Fasciola (27)
Hepatitis B virus (27)
Human betaherpesvirus 5 (27)
Madurella mycetomatis (27)
Mesocricetus auratus (27)
Miscanthus x giganteus (27)
Mus musculus (27)
Mycobacterium tuberculosis (27)
Orthoflavivirus (27)
Panicum virgatum (27)
Platyhelminthes (27)
Mus musculus (7)
Arabidopsis thaliana (3)
Clonorchis sinensis (1)
Saccharomyces cerevisiae (1)
Bos taurus (1)
Cardamine circaeoides (1)
Danio rerio (1)
Elaphe taeniura (1)
Oryctolagus cuniculus (1)
Pseudomonas syringae pv. tomato str. DC3000 (1)
Severe acute respiratory syndrome coronavirus 2 (1)
Triticum aestivum (1)

Repository

iProX (44)
pride (27)
biostudies-arrayexpress (12)
EGA (6)
MassIVE (4)
MetaboLights (3)
GNPS (1)
jPOST (1)

Tissue

Lung (4)
Cell culture (3)
Liver (3)
Leaf (2)
Abscission zone (1)
Colon (1)
Embryonic stem cell (1)
Heart (1)
Hypha (1)
JURKAT cell (1)
Midgut (1)
Pancreas (1)
Pancreatic ductal cell (1)
T cell (1)
Testis (1)
Uterine endometrium (1)

Disease

Acute leukemia (1)
Colon cancer (1)
Idiopathic pulmonary fibrosis (1)
Lung carcinoma (1)
Pancreatic cancer (1)

Technology Type

Mass Spectrometry (27)
Shotgun proteomics (12)
Bottom-up proteomics (5)
Mass spectrometry (3)
Data-dependent acquisition (3)
SWATH MS (3)
Affinity purification coupled with mass spectrometry proteomics (2)
Gel-based experiment (2)
Illumina HiSeq 2000, HiSeq X Ten, Illumina HiSeq 2500, ILLUMINA (1)
Data-independent acquisition (1)
Top-down proteomics (1)

Instrument Platform

Q Exactive (3)
Orbitrap Fusion Lumos (2)
Liquid Chromatography MS - positive - reverse phase (2)
Illumina Genome Analyzer IIx (1)
Illumina HiSeq 2500 (1)
Illumina HiSeq 2000 (1)
LTQ Orbitrap Velos (1)
Q Exactive HF (1)
Liquid Chromatography MS - positive - hilic (1)
Liquid Chromatography MS - negative - reverse phase (1)

Publication Date

2022 (16)
2021 (12)
2025 (8)
2020 (7)
2023 (7)
2014 (4)
2024 (4)
2019 (3)
2011 (2)
2010 (2)
2026 (2)
2015 (1)
2013 (1)
2012 (1)
2017 (1)

CHEBI ID

CHEBI:80705 (2)
CHEBI:3086 (2)
CHEBI:167742 (2)
CHEBI:28927 (2)
CHEBI:167719 (2)
CHEBI:167830 (2)
CHEBI:3088 (2)
CHEBI:167802 (2)
CHEBI:16330 (2)
CHEBI:28157 (2)
CHEBI:2781 (2)
CHEBI:4109 (2)
CHEBI:10043 (2)
CHEBI:89633 (2)
CHEBI:84940 (2)
CHEBI:89649 (2)
CHEBI:46372 (2)
CHEBI:17890 (2)
CHEBI:167858 (2)
CHEBI:27794 (2)
CHEBI:10275 (2)
CHEBI:7466 (2)
CHEBI:85881 (2)
CHEBI:66951 (2)
CHEBI:42223 (2)
CHEBI:2295 (2)
CHEBI:28918 (2)
CHEBI:6052 (2)
CHEBI:17252 (2)
CHEBI:30754 (2)

Metabolite Name

Isorhapontigenin (2)
Cathine (2)
Aflatoxin G2 (2)
Apocynin (2)
Noradrenaline (2)
Sakuranetin (2)
Isorhamnetin (2)
Isoferulic acid (2)
Esculetin (2)
Tetranor-12(S)-HETE (2)
Piceatannol (2)
Wogonin (2)
Epinephrine (2)
Acetophenone (2)
Emodin (2)
Valerophenone (2)
Arecoline (2)
Cuminaldehyde (2)
Prolylleucine (2)
Caprolactam (2)
Ecgonine (2)
Valylproline (2)
Betaine (2)
Artemisinin (2)
Propionylcarnitine (2)
Bialaphos (2)
Ethyl oleate (2)
Betulin (2)
Hesperetin (2)
Anthranilic acid (2)

Study type

Transcription profiling by array (5)
RNA-seq of coding RNA (5)
Comparative genomic hybridization by array (1)
Methylation profiling by high throughput sequencing (1)

Release Date

2025 (389)
2022 (340)
2023 (316)
2024 (295)
2021 (251)
2020 (184)
2019 (144)
2018 (89)
2017 (84)
2026 (68)
2015 (57)
2016 (55)
2014 (53)
2013 (25)
2012 (21)
2011 (9)
2010 (8)
2008 (7)
2009 (4)
2007 (1)
2006 (1)
2005 (1)
2004 (1)
2002 (1)

Lab affiliation

Abbvie Bioresearch Center (2)
Agronomy College, Henan Agricultural University, China (2)
Guangdong Pharmaceutical University (2)
Shanghai Institute of Thoracic Oncology, Shanghai Chest Hospital, Shanghai Jiao Tong University, Shanghai 200030 (2)
1 Cancer Institute, Xuzhou Medical University, Xuzhou, Jiangsu, China. 2 Center of Clinical Oncology, The Affiliated Hospital of Xuzhou Medical University, Xuzhou, China. 3 State Key Laboratory Jiangsu Center for the Collaboration and Innovation of Cancer Biotherapy, Cancer Institute, Xuzhou Medical University, Xuzhou, Jiangsu, China. (1)
AbbVie Bioresearch Center, Worcester, MA 01605, United States (1)
Chair, Cancer Biology & Genetics Program, SKI; Chair, Geoffrey Beene Cancer Research Center; Investigator, Howard Hughes Medical Institute; (1)
Chongqing Medical University (1)
College of Biomedical Engineering & Instrument Science,Zhejiang University (1)
College of Horticulture, Nanjing Agricultural University, China (1)
Department of Analytical Chemistry and CAS Key Laboratory of Receptor Research, Shanghai Institute of Materia Medica, Chinese Academy of Sciences, Shanghai, 201203, China (1)
Department of Biochemistry and Molecular Cell Biology, Key Laboratory of Cell Differentiation and Apoptosis of Chinese Ministry of Education, Shanghai Key Laboratory for Tumor Microenvironment and Inflammation, Shanghai Jiao Tong University School of Medicine, Shanghai, China (1)
Department of Microbiology & Molecular Genetics University of California, Irvine Irvine, California, 92697 USA (1)
Forest Pathology Laboratory, Colleage of Forest, Beijing Forestry University, China (1)
Key Lab of Agricultural Animal Genetics, Breeding and Reproduction of Ministry of Education, College of Animal Science and Technology, Huazhong Agricultural University, Wuhan 430070, China. (1)
Key Laboratory of Cell Proliferation and Differentiation of the Ministry of Education, School of Life Sciences, Peking-Tsinghua Center for Life Sciences, Peking University, Beijing 100871, China (1)
Nanjing Med Univ, State Key Lab Reprod Med, Dept Histol & Embryol, 140 Hanzhong Rd, Nanjing 210029, Jiangsu, Peoples R China. (1)
Research & Development, AbbVie, North Chicago, IL, 60064 (1)
Shanghai Institute of Thoracic Tumors, Shanghai Chest Hospital, Shanghai, 200030, China. (lab head) (1)
St Jude Children's Research Hospital (1)
State Key Laboratory of Microbial Metabolism, School of Life Sciences and Biotechnology, Shanghai Jiao Tong University, Shanghai 200240, China (1)
State Key Laboratory of Oral Diseases & National Clinical Research Center for Oral Diseases & National Engineering Laboratory for Oral Regenerative Medicine & Department of Oral and Maxillofacial Surgery, West China Hospital of Stomatology, Sichuan University (1)
Third Military Medical University (1)

Previous page
1 / 249
You're on page 1
page 2
page 3
page 4
page 5
page ...
page 249
Next page

Sort by:

Relevance

Page size

Ameliorative effects of Xue-Fu-Zhu-Yu decoction, Tian-Ma-Gou-Teng-Yin and Wen-Dan decoction on myocardial fibrosis in a hypertensive rat mode.

Not available

S-EPMC4744408 | biostudies-literature

Candidate proteins involved in the calyx abscission process of ‘Kuerlexiangli’ (Pyrus sinkiangensis Yu) identified by iTRAQ analysis

‘Kuerlexiangli’ (Pyrus sinkiangensis Yu) is an important market pear in China. The shape and quality of the fruit is negatively affected by the presence of a persistent calyx. Here, to explore the molecular mechanism of calyx abscission, we designed an experiment to compare protein expression at two...

ORGANISM(S): Pyrus x bretschneideri

2020-06-17 | PXD012499 | Pride